Related references
Note: Only part of the references are listed.Fluctuations in the concentration/dose ratio of calcineurin inhibitors after simeprevir administration in patients with recurrent hepatitis C after liver transplantation
Yoshihide Ueda et al.
TRANSPLANT INTERNATIONAL (2015)
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection
Hiromitsu Kumada et al.
HEPATOLOGY (2014)
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
R. J. Fontana et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Liver transplantation in the setting of chronic HCV
Norah Terrault
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Post-Liver Transplant Cholestatic Hepatitis C: A Systematic Review of Clinical and Pathological Findings and Application of Consensus Criteria
Torun K. Narang et al.
LIVER TRANSPLANTATION (2010)
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection
M Kugelmas et al.
LIVER TRANSPLANTATION (2003)
Interferon α 2B and ribavirin in severe recurrent cholestatic hepatitis C
JP Ong et al.
TRANSPLANTATION (2001)
Share Paper
